Overall rank by patents
#28,321
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView Foreign Corporation
Cambridge Glycoscience Ltd
USPTO PatentsView assignee record - 9 granted patents across 10 technology areas, active 2021–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A23L (FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF).
9
Total patents granted
10
CPC technology areas
21.7
Avg claims per patent
-
5-year filing velocity
The verdict
Cambridge holds 9 US patents across 10 technology areas, rank #28,321 of 50,000 tracked assignees.
- #28,321
- of 50,000 US assignees by volume
- Top 10%
- by Innovation Score (52.1/100)
- 21.7
- avg claims per patent
Portfolio overview
Cambridge Glycoscience Ltd has been granted 9 US utility patents between 2021 and 2025, placing Cambridge Glycoscience Ltd at rank #28,321 across all assignees tracked by PlainPatent. This portfolio spans 10 distinct Cooperative Patent Classification (CPC) subclasses, averaging 21.7 claims per patent with primary concentration in A23L (FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF). As a Foreign Corporation, Cambridge Glycoscience Ltd is one of the more focused assignees in the PatentsView dataset. By volume, Cambridge sits between C.m.c. S.p.a. (9 patents, rank #28,317) and Capartis Ag (9 patents, rank #28,325) - the closest US assignees by grant volume. The composite Innovation Score of 52.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2021 through 2025, with 9 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Cambridge Glycoscience Ltd's 21.7 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 10 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Cambridge Glycoscience Ltd against peers pursuing similar technology classes.
Who files at Cambridge's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- C M C S p A
C.M.C. S.p.A.
9 patents
- C2sense
C2Sense, Inc.
9 patents
- C3
C3 Corporation
9 patents
- Calyxia
CALYXIA
9 patents
- CAME S p A
CAME S.p.A.
9 patents
- Canadian Solar Ma…
CANADIAN SOLAR MANUFACTURING (CHANGSHU) INC.
9 patents
- Cancer Hospital C…
CANCER HOSPITAL, CHINESE ACADEMY OF MEDICAL SCIENCES
9 patents
- Capartis
CAPARTIS AG
9 patents
- Cambridge Glycosc… ◀
CAMBRIDGE GLYCOSCIENCE LTD
9 patents
What this shows Cambridge holds 9 patents at rank #28,321, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Cambridge
By rank, the assignees closest to #28,321 in granted patent volume.
- C.m.c. S.p.a. #28,317 · 9 patents
- C2sense, Inc. #28,318 · 9 patents
- C3 Corporation #28,319 · 9 patents
- Calyxia #28,320 · 9 patents
- CAME S.p.a. #28,322 · 9 patents
- Canadian Solar Manufacturing (changshu) Inc. #28,323 · 9 patents
- Cancer Hospital, Chinese Academy OF Medical Sciences #28,324 · 9 patents
- Capartis Ag #28,325 · 9 patents
Leaders in A23L (Foods)
Other assignees with the most granted patents in Cambridge's primary technology class.
Cambridge's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
52 Top 10% higher than 90% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2021 | 1 | 11.1% |
| 2022 | 2 | 22.2% |
| 2023 | 2 | 22.2% |
| 2024 | 2 | 22.2% |
| 2025 | 2 | 22.2% |
Which technologies does Cambridge Glycoscience Ltd patent most?
Top 10 of 10 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Focused
Claim Depth Complex
Frequently Asked Questions
How many patents does Cambridge Glycoscience Ltd hold?
Cambridge Glycoscience Ltd holds 9 US granted patents filed between 2021 and 2025, spanning 10 technology areas.
What is Cambridge Glycoscience Ltd's Innovation Score?
Cambridge Glycoscience Ltd has an Innovation Score of 52.1 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Cambridge Glycoscience Ltd focus on?
Cambridge Glycoscience Ltd's top technology area is A23L (FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF) with 8 patents. The company has filed patents in 10 CPC subclasses total.
Is Cambridge Glycoscience Ltd's patent filing rate increasing or decreasing?
Insufficient historical data is available to calculate a velocity trend for Cambridge Glycoscience Ltd.
What does claim depth mean for Cambridge Glycoscience Ltd's patents?
Cambridge Glycoscience Ltd's patents average 21.7 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.
How is the Cambridge Glycoscience Ltd patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
Cambridge's 9 grants land it in the top 10% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - Cambridge ranks #28,321 of 50,000. Top 50 holders
- Most of this portfolio concentrates in A23L - see who else leads that technology area. A23L leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.